News

The Houston-based Empower Pharmacy is seeking to dismiss a lawsuit that targets its ability to sell popular diabetes and ...
Eli Lilly continues to dominate the obesity market with Zepbound and Orforglipron, leading JPMorgan to see it as a top pick ...
Eli Lilly ( LLY 0.36%) has been a great growth pick for investors over the past few years. The pharma company, thanks to its ...
Since the FDA said shortages of Wegovy and Zepbound are over, compounding pharmacies are supposed to stop making copies of the drugs. But some of those business are trying to find ways to continue.
Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...
Donation Options Search Search Search Boxes of the weight-loss medications Wegovy and Zepbound. JoNel Aleccia / AP Share Excess body weight can raise the risk of certain cancers. So researchers ...
The Trump administration plans to broaden restrictions on China’s tech sector with new regulations to capture subsidiaries of companies under US curbs. Officials are drafting a rule that would ...
Talk to your healthcare provider about how you can take part in this registry, or you may contact Lilly at 1-800-LillyRx (1-800-545-5979). Zepbound ... between our sales teams and authors ...
Eli Lilly, the maker of Zepbound, is emerging as a market leader with strong growth in revenue and a robust drug pipeline. Elevated implied volatility (IV Rank ~40) makes Lilly an ideal candidate for ...
(RTTNews) - Eli Lilly and Company (LLY), Tuesday announced an agreement regarding the acquisition of SiteOne Therapeutics, Inc., a private biotechnology company, for upto $1 billion in cash ...
used in Lilly's type 2 diabetes drug Mounjaro is "Ireland's biggest pharmaceutical export to the U.S." This API is also used in the company's weight-loss drug, Zepbound. The Irish newspaper ...
MILAN, May 27 (Reuters) - The United States has warned Pirelli (PIRC.MI), opens new tab that sales of vehicles fitted with its data-collecting technology could be restricted due to concerns over ...